Inventor · disambiguated record
Bernd Kaiser
Also filed as: KAISER BERND
5 granted patents·10 pending applications·91 citations·filing 2002–2015
82Inventor score
Top patents by PatentIndex Score
15 records- 0194US7132445B23,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted Nov 7, 2006·58 cites·82 claims
- 0288US7964646B23,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2006·Granted Jun 21, 2011·10 cites·47 claims
- 0388US7947720B23,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2009·Granted May 24, 2011·10 cites·4 claims
- 0487US10669296B2LXR agonists and uses thereofRGENIX INC·Filed 2015·Granted Jun 2, 2020·6 cites·19 claims
- 0572US7179807B25-substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2003·Granted Feb 20, 2007·7 cites·15 claims
- 0653US2011213029A13,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor LigandsSCHERING CORP·Filed 2011·Application pending·0 cites
- 0752US2004106794A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsSCHERING CORP·Filed 2002·Application pending·0 cites
- 0850US2006199823A1Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligandsNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 0950US2007043056A15-Substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 1049US2005113379A1Heteroaryl fused pyridines, pyrazines and pyrimidines as CRF1 receptor ligandsFiled 2004·Application pending·0 cites
- 1146US2004235908A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsSCHERING CORP·Filed 2004·Application pending·0 cites
- 1244US2003204085A13, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonistsFiled 2002·Application pending·0 cites
- 1343US2005070542A15-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compoundsFiled 2004·Application pending·0 cites
- 1439US2003097004A13,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonistsSCHERING CORP·Filed 2002·Application pending·0 cites
- 1535US2004097547A13,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligandsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bernd Kaiser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →